The Neurological Examination: What to Expect

The neurological examination is a structured clinical assessment of the nervous system performed by a licensed physician or advanced practice provider to evaluate brain, spinal cord, and peripheral nerve function. It serves as the primary diagnostic gateway for conditions ranging from stroke and epilepsy to peripheral neuropathy and movement disorders. Understanding its components helps patients and caregivers recognize what each phase measures and why the sequence matters.

Definition and scope

A neurological examination is a systematic, non-invasive bedside assessment that evaluates the functional integrity of the central and peripheral nervous systems. The examination is distinct from neuroimaging and electrodiagnostic studies — it generates clinical findings that guide whether further testing such as an EEG, MRI, or EMG and nerve conduction study is warranted.

The American Academy of Neurology (AAN) recognizes the neurological examination as the foundation of neurological diagnosis, and its components map directly to the anatomical structures described in brain and nervous system anatomy. The examination scope covers six functional domains: mental status, cranial nerves, motor system, sensory system, coordination and gait, and reflexes. Each domain corresponds to a discrete anatomical level of the nervous system, allowing an experienced examiner to localize a lesion before any imaging is ordered.

The broader regulatory context for neurological practice in the United States — including Centers for Medicare & Medicaid Services (CMS) evaluation and management coding guidelines — requires documentation of the neurological examination components to support appropriate billing levels under the Current Procedural Terminology (CPT) framework maintained by the American Medical Association (AMA).

How it works

The examination proceeds in a predictable sequence to avoid missing findings and to allow a logical anatomical interpretation of results.

  1. Mental status assessment — The examiner evaluates orientation, attention, language, memory, and executive function. Standardized instruments such as the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA) may be incorporated. Deficits at this stage suggest cortical or subcortical dysfunction.

  2. Cranial nerve testing — All 12 cranial nerve pairs are assessed. Testing includes visual acuity and fields (CN II), pupillary light response (CN II, III), extraocular movements (CN III, IV, VI), facial sensation (CN V), facial symmetry (CN VII), hearing (CN VIII), palate elevation (CN IX, X), shoulder shrug (CN XI), and tongue protrusion (CN XII). Abnormalities localize pathology to the brainstem or cranial nerve tracts — relevant in conditions discussed under Bell's palsy and cranial nerve disorders.

  3. Motor system evaluation — Muscle bulk, tone, and strength are graded on the Medical Research Council (MRC) scale, which runs from 0 (no contraction) to 5 (normal strength against full resistance). Upper motor neuron lesions produce spasticity and hyperreflexia; lower motor neuron lesions produce flaccidity and atrophy.

  4. Sensory testing — Light touch, pinprick, vibration (using a 128 Hz tuning fork), proprioception, and temperature discrimination are tested in a dermatomal pattern. Dissociated sensory loss — where one modality is impaired while another is preserved — is a key localizing finding in spinal cord disease and peripheral neuropathy.

  5. Coordination and gait — Finger-to-nose and heel-to-shin testing assess cerebellar function. Romberg testing distinguishes sensory ataxia from cerebellar ataxia. Gait analysis detects patterns including spastic, steppage, antalgic, or parkinsonian gaits.

  6. Deep tendon reflexes — Reflexes are graded on a 0–4+ scale (National Institute of Neurological Disorders and Stroke, NINDS). Pathological reflexes such as the Babinski sign, when present in adults, indicate upper motor neuron dysfunction.

The total examination typically requires 20 to 45 minutes for a comprehensive initial assessment, though focused follow-up examinations may take under 10 minutes.

Common scenarios

The neurological examination is deployed across a broad range of clinical presentations. Three high-frequency contexts illustrate its role:

Acute stroke evaluation — In emergency settings, the National Institutes of Health Stroke Scale (NIHSS), a standardized 15-item neurological examination scoring tool, quantifies stroke severity on a 0–42 point scale. An NIHSS score of 0–5 indicates mild deficit; scores above 25 indicate very severe deficit. The NIHSS directly informs triage, thrombolytic eligibility, and thrombectomy candidacy under protocols aligned with American Heart Association/American Stroke Association guidelines (AHA/ASA Stroke Guidelines).

Epilepsy workup — Post-seizure neurological examination findings — focal weakness (Todd's paralysis), language deficits, or altered sensorium — help localize seizure onset zones and inform urgency of follow-up EEG testing. The International League Against Epilepsy (ILAE) classification system links examination findings to seizure type classification.

Parkinson's disease assessment — The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) incorporates structured neurological examination components, including rigidity grading and postural instability testing, across a 0–4 severity scale per item. This scale is referenced in Parkinson's disease clinical management.

Decision boundaries

The neurological examination defines two critical branching points in the diagnostic pathway.

Normal versus abnormal findings — A structurally normal examination in a patient with symptoms such as headache or dizziness substantially narrows the differential diagnosis and may direct workup toward non-neurological causes. A focal abnormality — for example, a unilateral Babinski sign or asymmetric reflexes — requires imaging regardless of symptom acuity.

Localization versus non-localization — The examination either produces a coherent anatomical localization (e.g., right hemisphere cortex, cervical spinal cord, peripheral nerve) or it does not. Non-localizing findings with significant subjective complaints trigger neuropsychological testing or functional neurological disorder evaluation protocols. Localized findings drive targeted imaging: a suspected posterior fossa lesion prompts MRI with posterior fossa sequences; suspected cervical myelopathy prompts MRI of the cervical spine.

The examination also functions as a safety screen. Findings consistent with acute herniation (fixed and dilated pupil, decorticate posturing) or rapidly progressive weakness consistent with Guillain-Barré syndrome trigger immediate escalation pathways, as framed in safety context and risk boundaries for neurological conditions. Patients uncertain about when symptoms warrant formal evaluation can review signs you should see a neurologist for structured guidance.

The neurological authority home provides a structured overview of the full scope of neurological conditions, diagnostic tools, and treatment approaches covered across this reference resource.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)